You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bronchial Neoplasms

Showing 1 - 25 of 2,544
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer With Machine Learning Based on Routine Clinical

Not yet recruiting
  • Adenocarcinoma of Lung; Bronchial Neoplasms; Early Detection of Cancer; Machine Learning
  • Observational
  • Golnik, Slovenia
  • +1 more
Jun 8, 2023

New Open Source Virtual Bronchoscope Navigation System

Suspended
  • Bronchial Neoplasms
  • Fraxinus VBN system
  • Trondheim, Norway
    St Olavs Hospital
Nov 29, 2021

Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Placebo)

Completed
  • Neoplasms
  • +14 more
  • San Antonio, Texas
    The START Center for Cancer Care
Apr 21, 2022

Narrow Band Imaging Bronchoscopy in Detecting Bronchial Squamous

Enrolling by invitation
  • Pulmonary Cancer
  • Lung Cancer
    • Jakarta Pusat, DKI Jakarta, Indonesia
      Faculty of Medicine
    Oct 27, 2023

    Lung Cancer Trial in Busan (Ultrathin bronchoscopy with intratumoral washing)

    Not yet recruiting
    • Lung Cancer
    • Ultrathin bronchoscopy with intratumoral washing
    • Busan, Korea, Republic of
      Pusan National University hospital
    Nov 17, 2023

    Lung Cancer Trial (bronchoscope)

    Not yet recruiting
    • Lung Cancer
    • bronchoscope
    • (no location specified)
    Aug 8, 2023

    Bronchial Tumors Trial in Trondheim (navigated bronchoscopy)

    Recruiting
    • Bronchial Neoplasms
    • navigated bronchoscopy
    • Trondheim, Norway
      Department of Thoracic Medicine, St Olavs Hospital
    Dec 29, 2021

    Bronchial Tumors Trial in Germany, Spain (EGF816, Trametinib)

    Recruiting
    • Bronchial Neoplasms
    • Cologne, Germany
    • +6 more
    Nov 2, 2022

    Lung Tumor Malignant, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-451)

    Recruiting
    • Lung Neoplasm Malignant
    • +18 more
    • Fairfax, Virginia
      New Experimental Therapeutics of Virginia (NEXT Oncology)
    Mar 29, 2022

    NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in Worldwide (Furmonertinib)

    Recruiting
    • Non-Small Cell Lung Cancer
    • +14 more
    • Glendale, California
    • +12 more
    Feb 2, 2023

    Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE

    Not yet recruiting
    • Bronchial and Thymic Neuroendocrine Tumour
    • +3 more
    • Lu-177 DOTATATE (Lutathera®)
    • (no location specified)
    Nov 1, 2023

    Hemoptysis, Malignant Tumor, Lung Cancer Trial (Technicium 99 MAA infusion)

    Withdrawn
    • Hemoptysis
    • +2 more
    • Technicium 99 MAA infusion
    • (no location specified)
    Aug 15, 2022

    Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Pembrolizumab)

    Completed
    • Neoplasms
    • +13 more
    • San Antonio, Texas
      The START Center for Cancer Care
    Jan 24, 2022

    Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

    Recruiting
    • Lung Neoplasm
    • +26 more
    • Boston, Massachusetts
    • +6 more
    Jun 23, 2022

    Neuroendocrine Tumors, Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors Trial in New York (177Lu-DOTATATE)

    Recruiting
    • Neuroendocrine Tumors
    • Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 19, 2023

    Lung Tumors, Squamous Cell Lung Cancer, Adenocarcinoma of the Lung Trial in Guangzhou (Icotinib)

    Recruiting
    • Lung Neoplasms
    • +6 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Jul 29, 2021

    Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

    Terminated
    • Neoplasms
    • +27 more
    • Culver City, California
    • +28 more
    Jul 25, 2022

    NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)

    Recruiting
    • Non-Small Cell Lung Cancer
    • +13 more
    • furmonertinib 240 mg
    • +2 more
    • Yuma, Arizona
    • +37 more
    Dec 14, 2022

    Bronchial Epithelial Dysplasia, COPD, Lung Carcinoma Trial in United States (procedure, drug, other)

    Not yet recruiting
    • Bronchial Epithelial Dysplasia
    • +5 more
    • Biospecimen Collection
    • +5 more
    • Aurora, Colorado
    • +4 more
    Aug 4, 2022

    Advanced Lung Carcinoid Tumor, Functioning Lung Carcinoid Tumor, Locally Advanced Lung Neuroendocrine Tumor Trial in Boston,

    Recruiting
    • Advanced Lung Carcinoid Tumor
    • +11 more
    • Boston, Massachusetts
    • +1 more
    Jul 19, 2022

    Effectiveness of Care in Certified Cancer Centres in Germany

    Completed
    • Colorectal Cancer
    • +9 more
    • Oncological certification
    • Dresden, Sachsen, Germany
      Technische Universität Dresden
    Aug 22, 2022

    Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

    Recruiting
    • Lung Neoplasms
    • +23 more
    • La Jolla, California
    • +35 more
    Oct 6, 2022

    Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1

    Recruiting
    • Lung Cancer
    • +11 more
    • Recombinant oncolytic herpes simplex virus type 1 (R130)
    • Anqing, Anhui, China
      The PLA Navy Anqing Hospital
    May 23, 2023

    RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

    Active, not recruiting
    • RET-altered Non Small Cell Lung Cancer
    • +39 more
    • pralsetinib (BLU-667)
    • Phoenix, Arizona
    • +65 more
    Nov 10, 2022

    Pralsetinib to Best Available Therapy in RET-Fusion Positive

    Enrolling by invitation
    • RET-fusion Non Small Cell Lung Cancer
    • +16 more
      • New York, New York
      • +2 more
      Aug 9, 2021